Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron and its subvariants (BA.2, BA.4, BA.5) represented the most commonly circulating variants of concern (VOC) in the coronavirus disease 2019 (COVID-19) pandemic in 2022. Despite high vaccination rates with approved SARS-CoV-2 vaccine...

Full description

Bibliographic Details
Main Authors: Nicole Roth, Janina Gergen, Kristina Kovacikova, Stefan O. Mueller, Lorenz Ulrich, Jacob Schön, Nico Joel Halwe, Charlie Fricke, Björn Corleis, Anca Dorhoi, Donata Hoffmann, Martin Beer, Domenico Maione, Benjamin Petsch, Susanne Rauch
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/2/318